Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2000
10/25/2000CN1271361A Tetrazole-containing rapamycin analogs with shortened half-lives
10/25/2000CN1271359A Novel compounds
10/25/2000CN1271357A bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors
10/25/2000CN1271342A Synthesis of clasto-lactacystin-beta-lactone and analogs thereof
10/25/2000CN1271284A Vitronectin receptor antagonist
10/25/2000CN1271283A Endothelin antogonist and a renin-angiotensin system inhibitor as a combined preparation
10/25/2000CN1271282A Oral compositions of levosimendan
10/25/2000CN1271279A Amide derivatives for the treatment of diseases mediated by cytokines
10/25/2000CN1270959A 4-phenyl pyridine derivatives
10/25/2000CN1270830A Sanjiangcha tea for reducing blood sugar, blood pressure and blood lipoid and its preparation
10/25/2000CN1270817A Tea-oil general saponin for preventing and treating cardiac and cerebral vascular diseases and preparation thereof
10/25/2000CN1057760C Amino acid substituted benzoylguanidines, process for their preparation, their use and medicament containing them
10/25/2000CN1057759C Alkyl-5-methyl sulfonylbenzoy/guanidine
10/25/2000CN1057758C antiarrhythmic (S)-enantiomers of methanesulfonamides
10/25/2000CN1057699C Capsule for treating apoplexy sequela and its producing method
10/25/2000CN1057678C External use medicine for treatment of cerebrovascular disease
10/25/2000CN1057672C Medicine for curing cerebrovascular disease
10/24/2000US6137002 Glycoprotein IIb/IIIa antagonists
10/24/2000US6136974 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
10/24/2000US6136953 Human antiproliferative polypeptide for the detection of vascular injuries
10/24/2000US6136862 Intravenously administering an organic acid, ester, or salt thereof
10/24/2000US6136861 Bicyclo[2.2.1]heptanes and related compounds
10/24/2000US6136859 Mixture of selenmethionine, carotene, ascorbic acid, tocopherol, methionine and coenzyme q10 in a carrier
10/24/2000US6136848 Antiallergens; asthma therapy
10/24/2000US6136843 Indole derivatives useful as endothelin receptor antagonists
10/24/2000US6136842 Sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives
10/24/2000US6136839 Using a sulfone or sulfoamide benzene compound
10/24/2000US6136829 Nitric oxide synthetase inhibitors
10/24/2000US6136828 Endothelin receptor antagonists
10/24/2000US6136825 Sulfonamide compounds having 5-HT receptor activity
10/24/2000US6136819 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations
10/24/2000US6136805 Quinoxaline dione derivatives, their production and their use in medicaments
10/24/2000US6136800 Steroids
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000CA2221148C Muscle trophic factor
10/24/2000CA2137445C Naphtalene derivates, process for their preparation and pharmaceutical compositions containing them
10/24/2000CA2047702C Serpin resistant chymotrypsin superfamily proteases particularly pai-1 resistant t-pa, complementary inhibitor mutants; compositions; genes; expression
10/24/2000CA2021547C Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins
10/19/2000WO2000062067A1 Novel transduction molecules and methods for using same
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061772A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061742A2 Treatment of cardiac power failure using s100 proteins
10/19/2000WO2000061631A1 Modified pentapeptide antagonists of the atrial natriuretic peptide clearance receptor
10/19/2000WO2000061628A1 49 human secreted proteins
10/19/2000WO2000061625A1 48 human secreted proteins
10/19/2000WO2000061622A2 Genes associated with diseases of the kidney
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061609A2 Prodrugs of thrombin inhibitors
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061606A1 Novel human voltage-gated potassium channel
10/19/2000WO2000061604A2 Pharmaceutical compounds
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061587A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
10/19/2000WO2000061583A1 Xanthine derivatives and analogs as cell signaling inhibitors
10/19/2000WO2000061582A1 Substituted fused imidazole derivatives
10/19/2000WO2000061580A1 Substituted bicyclic heteroaryl compounds as integrin antagonists
10/19/2000WO2000061579A1 New endothelin converting enzyme inhibitors, their production and their use
10/19/2000WO2000061576A1 Triarylimidazoles
10/19/2000WO2000061571A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
10/19/2000WO2000061568A2 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof
10/19/2000WO2000061557A1 4-hydroxypiperidine derivatives having antiarrhythmic effect
10/19/2000WO2000061556A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
10/19/2000WO2000061553A1 2-aminoethyl-indole derivatives, their preparation and therapeutic use
10/19/2000WO2000061551A2 Pyrimidine-2-one derivatives as integrin receptor ligands
10/19/2000WO2000061550A1 Prostaglandin e1 derivatives
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061539A1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors
10/19/2000WO2000061189A2 Water-soluble compositions of bioactive lipophilic compounds
10/19/2000WO2000061188A1 Sodium channel blocker compositions and the use thereof
10/19/2000WO2000061180A2 Products and methods for treating ptp lar related diseases
10/19/2000WO2000061171A2 Uses of mammalian ox2 protein and related reagents
10/19/2000WO2000061164A1 Modulation of excitable tissue function by peripherally administered erythropoietin
10/19/2000WO2000061144A1 Method and means for preventing, treating, and diagnosing cardiovascular complications in patients with obstructive sleep apnea
10/19/2000WO2000061138A1 Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
10/19/2000WO2000061136A1 Anticonvulsant derivatives useful in lowering blood pressure
10/19/2000WO2000060943A1 Prevention of brain damage in stroke
10/19/2000WO2000041505A3 Anthranilic acid derivatives
10/19/2000WO2000039290A8 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid
10/19/2000WO2000037641A3 Vascular endothelial growth factor-x
10/19/2000WO2000035475A3 Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia
10/19/2000WO2000034780A3 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3?
10/19/2000WO2000019883A9 Compositions and methods of disease diagnosis and therapy
10/19/2000WO2000013702A9 Use of an angiogenic factor for the treatment of microvascular angiopathies
10/19/2000WO2000012720A8 Elongase genes and uses thereof
10/19/2000DE19917930A1 Treating estrogen deficiency associated disorders, e.g. menopausal problems, osteoporosis, neoplasia or neurodegenerative disease, using new or known ent-steroids having bone-selective estrogenic activity
10/19/2000DE19917505A1 Treating cytokine-mediated diseases, e.g. asthma, allergy, eczema, rheumatoid arthritis or transplant rejection, using new or known maduraphthalazine derivatives
10/19/2000DE19917233A1 New stable, soluble crystalline sodium salt of 5-chloro-2-methoxy-N-(2-phenylethyl)-benzamide derivative, is an ATP-sensitive potassium channel blocker useful e.g. for treating cardiac arrhythmia or ischemia
10/19/2000DE19916837A1 New di- or tetrahydro-benzoazulene derivatives, are integrin inhibitors useful e.g. for treating thrombosis, coronary heart disease, arteriosclerosis, tumors, osteoporosis or rheumatoid arthritis
10/19/2000DE19916719A1 Neue ECE-Inhibitoren, ihre Herstellung und Verwendung New ECE inhibitors, their preparation and use
10/19/2000DE19915602A1 3-Amino-4-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-4-arylpropan-1-ol-derivatives, their preparation and use
10/19/2000DE19915601A1 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-3-arylpropan-1-ol-derivatives, their preparation and use
10/19/2000DE19915485A1 Therapie der Herzinsuffizienz Treatment of heart failure
10/19/2000CA2760534A1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000CA2383940A1 Modulation of excitable tissue function by peripherally administered erythropoietin
10/19/2000CA2371172A1 50 human secreted proteins
10/19/2000CA2370767A1 49 human secreted proteins
1 ... 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 ... 1595